Grenke

On 07.10.2026 Dr. Sebastian Hirsch expanded his portfolio by 1,500 grenke shares at €9.83 each; the transaction was disclosed on 08.10.2026. In FSE trading the stock initially fell to €9.84 but rose to €9.88 by the close on the day of the BaFin filing. grenke has a market capitalization of €429.85 million and a free float of 44,177,904 shares. Previously, on 13.05.2026 Hirsch had already purchased 1,000 shares at €12.24 each. » Więcej na finanzen.net

The Grenke stock is trading at a new multi-year low, even though the company sees opportunities for higher growth and profit momentum. In H1 2026, new business rose only moderately by 1.4% to EUR 1.64 billion; the loss ratio was 2%, while earnings improved by 24% to EUR 32.6 million. For 2026, Grenke is targeting an annual profit of EUR 74–86 million and new business at the lower end of the target range (EUR 3.4–3.6 billion); medium-term return on equity is to rise to around 10% by 2030. The strategic focus remains on cost and portfolio discipline and on expanding market share, for example in Italy (cooperation with Intesa Sanpaolo) and in the USA. » Więcej na finanzen.net

Grenke reported a group profit of €32.6m for H1 2026 (up 24.4%) and an operating result of €353m (up 11%). Operating expenses rose by only 1.5%, bringing the cost-income ratio down to 51.6%. New leasing business grew to €1.6bn, the US business doubled, and total assets stood at €9.2bn. The group confirmed its full-year guidance of €74–86m profit but sees risks from weak investment demand and increased credit risk. » Więcej na de.investing.com

Grenke’s new leasing business fell 1% year-on-year in Q2 to €858.5m, and the contribution margin dropped 1.5 percentage points to 15.6%. The loss ratio rose from 1.7% to 2.1%, yet group profit increased to €17.1m (+7%). CEO Sebastian Hirsch confirmed the annual guidance: new leasing business is expected to climb to €3.4–3.6bn and net profit to rise to €74–86m. The stock reacted negatively and traded well below the level at the start of the year. » Więcej na finanzen.net

Board member Dr. Martin Paal acquired a total of 750 grenke shares on 13.05.2026 at EUR 12.71 each. The stock was largely unchanged in FSE trading; grenke is valued at around EUR 542.5 million and 44,177,904 shares are tradable. Previously, supervisory board member Freisleben bought 500 shares at EUR 12.94 each on 10.04.2026. » Więcej na finanzen.net